CDK-IN-14
Product Specifications
Target
CDK, Apoptosis, Caspase
Related Pathways
Apoptosis, Proteases/Proteasome, Cell Cycle/Checkpoint
Bioactivity
CDK-IN-14 (B34) is a CDK2 inhibitor (IC50=0.097 μM) that exhibits anti-hepatocellular carcinoma activity. It inhibits the cell cycle in HepG-2 cancer cells and induces apoptosis (apoptosis) through a caspase-mediated mechanism.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7063147 Inquire
Recombinant Bifidobacterium adolescentis Lipoprotein signal peptidase (lspA), partial
Sign In for Pricing
View Details K2490307 1.0 µg DNA
TRNAG24 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
MBS6263874-01 0.1 mL
Carcinoembryonic Antigen (CEA, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5, CEACAM5, CD66e, CD66e Antigen, Meconium Antigen 100) (MaxLight 490)
Sign In for Pricing
View Details MBS6263874-02 5x 0.1 mL
Carcinoembryonic Antigen (CEA, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5, CEACAM5, CD66e, CD66e Antigen, Meconium Antigen 100) (MaxLight 490)
Sign In for Pricing
View Details 